Dec 22, 2017
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.06 to $0.00.
The split itself did not change the total investment value.
Biostage, Inc. (BSTG) trades on the Other OTC in the Biotechnology industry.
Biostage, Inc. company overviewThe latest split shown was on December 22, 2017. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on December 22, 2017.